<?xml version="1.0"?>
<Articles JournalTitle="Frontiers in Biomedical Technologies">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Frontiers in Biomedical Technologies</JournalTitle>
      <Issn>2345-5837</Issn>
      <Volume>0</Volume>
      <Issue>0</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>11</Month>
        <Day>05</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Phenolic Acid-Functionalized Gold Nanoparticles: A Theranostic Approach to Radiosensitization and CT Contrast Enhancement in Breast Cancer</title>
    <FirstPage>1711</FirstPage>
    <LastPage>1711</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Elahe</FirstName>
        <LastName>Hajisattari</LastName>
        <affiliation locale="en_US">Department of Radiology, Faculty of Paramedical Sciences, Ardabil University of Medical Sciences, Ardabil, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zeynab</FirstName>
        <LastName>Seraj</LastName>
        <affiliation locale="en_US">Department of Biomedical Engineering and Medical physics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Amiri</LastName>
        <affiliation locale="en_US">Department of Medical Physics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Solhi</LastName>
        <affiliation locale="en_US">Department of Radiology, Faculty of Paramedical Sciences, Ardabil University of Medical Sciences, Ardabil, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2026</Year>
        <Month>09</Month>
        <Day>04</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>10</Month>
        <Day>04</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Abstract
&#xD;

Purpose:&#xA0;Radiotherapy resistance and inadequate CT contrast sensitivity limit the efficacy of breast cancer management. This study introduces a theranostic platform based on gallic acid&#x2011;functionalized gold nanoparticles (Au@GA NPs) for dual radiosensitization and CT contrast enhancement.
&#xD;

Methods:&#xA0;Au@GA NPs were green&#x2011;synthesized using gallic acid as both reducing and capping agent. Physicochemical properties were characterized by UV&#x2011;Vis, XRD, SEM, and TEM. Cytotoxicity and radiosensitization were evaluated in MCF&#x2011;7 (cancer) and MCF&#x2011;10 (normal) cells using MTT assay combined with 6&#x202F;MV X&#x2011;ray irradiation (4&#x202F;Gy). CT contrast performance was compared with Omnipaque (iohexol 300) at 80, 120, and 160&#x202F;kVp. Apoptosis was quantified via Annexin&#x202F;V&#x2011;FITC/PI flow cytometry.
&#xD;

Results:&#xA0;Spherical Au@GA NPs (~20&#x202F;nm) exhibited a characteristic SPR peak at 520&#x202F;nm. Selective cytotoxicity was observed: MCF&#x2011;7 viability decreased to ~68% at 200&#x202F;&#x3BC;g/mL, while MCF&#x2011;10 remained &gt;82%. Combination with 4&#x202F;Gy irradiation reduced MCF&#x2011;7 viability to 39% (vs. 78% without NPs), demonstrating potent radiosensitization. CT attenuation of Au@GA NPs was up to&#xA0;2.5&#x2011;fold higher&#xA0;than Omnipaque at 80&#x202F;kVp. Flow cytometry revealed that the combined treatment induced&#xA0;81.9% total non&#x2011;viable cells&#xA0;(53.7% late apoptosis), versus 25.7% for radiation alone.
&#xD;

Conclusion:&#xA0;The Au@GA NP platform offers a dual&#x2011;function strategy&#x2014;enhancing tumor radiosensitivity while providing superior CT contrast&#x2014;positioning it as a promising candidate for image&#x2011;guided radiotherapy (IGRT) in breast cancer.</abstract>
    <web_url>https://fbt.tums.ac.ir/index.php/fbt/article/view/1711</web_url>
    <pdf_url>https://fbt.tums.ac.ir/index.php/fbt/article/download/1711/595</pdf_url>
  </Article>
</Articles>
